PMDA — authorised 26 September 2022
- Marketing authorisation holder: TAISHO PHARMACEUTICAL CO., LTD.
- Status: approved
🇯🇵 Nanozora in Japan
PMDA authorised Nanozora on 26 September 2022
Marketing authorisation
Nanozora in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Nanozora approved in Japan?
Yes. PMDA authorised it on 26 September 2022.
Who is the marketing authorisation holder for Nanozora in Japan?
TAISHO PHARMACEUTICAL CO., LTD. holds the Japanese marketing authorisation.